28341196|t|The use of intraosseous needles for injection of contrast media for computed tomographic angiography of the thoracic aorta
28341196|a|The objective of this study is to evaluate the safety and quality of computed tomographic angiography of the thoracic aorta (CTA-TA) exams performed using intraosseous needle intravenous access (ION-IVA) for contrast media injection (CMI). All CTA-TA exams at the study institution performed between 1/1/2013 and 8/14/2015 were reviewed retrospectively to identify those exams which had been performed using ION-IVA (ION-exams). ION-exams were then analyzed to determine aortic attenuation and contrast-to-noise ratio (CNR). Linear regression was used to determine how injection rate and other variables affected image quality for ION-exams. Patient electronic medical records were reviewed to identify any adverse events related to CTA-TA or ION-IVA. 17 (âˆ¼0.2%) of 7401 exams were ION-exams. ION-exam CMI rates varied between 2.5 and 4 ml/s. Mean attenuation was 312 HU (SD 88 HU) and mean CNR was 25 (SD 9.9). A strong positive linear association between attenuation and injection rate was found. No immediate or delayed complications related to the ION-exams, or intraosseous needle use in general, occurred. For CTA-TA, ION-IVA appears to be a safe and effective route for CMI at rates up to 4 ml/s.
28341196	11	31	intraosseous needles	T074	C1322770
28341196	36	45	injection	T061	C1533685
28341196	49	63	contrast media	T130	C0009924
28341196	68	100	computed tomographic angiography	T060	C1536105
28341196	108	122	thoracic aorta	T023	C1522460
28341196	145	150	study	T062	C2603343
28341196	157	165	evaluate	T058	C0220825
28341196	170	176	safety	T068	C0036043
28341196	181	188	quality	T080	C0332306
28341196	192	224	computed tomographic angiography	T060	C1536105
28341196	232	246	thoracic aorta	T023	C1522460
28341196	248	254	CTA-TA	T060	C0430022
28341196	256	261	exams	T169	C4284036
28341196	278	316	intraosseous needle intravenous access	T060	C0430022
28341196	318	325	ION-IVA	T060	C0430022
28341196	331	355	contrast media injection	T060	C2733072
28341196	357	360	CMI	T060	C2733072
28341196	367	373	CTA-TA	T060	C0430022
28341196	374	379	exams	T169	C4284036
28341196	387	392	study	T062	C2603343
28341196	393	404	institution	T073,T093	C0018704
28341196	460	475	retrospectively	T080	C1514923
28341196	494	499	exams	T169	C4284036
28341196	531	538	ION-IVA	T060	C0430022
28341196	540	549	ION-exams	T059	C0022885
28341196	552	561	ION-exams	T059	C0022885
28341196	594	612	aortic attenuation	T033	C3281005
28341196	617	640	contrast-to-noise ratio	T081	C0456603
28341196	642	645	CNR	T081	C0456603
28341196	648	665	Linear regression	T081	C0023733
28341196	692	701	injection	T061	C1533685
28341196	702	706	rate	T081	C1521828
28341196	717	726	variables	T080	C0439828
28341196	736	749	image quality	T080	C0806487
28341196	754	763	ION-exams	T059	C0022885
28341196	765	772	Patient	T101	C0030705
28341196	773	799	electronic medical records	T170	C2362543
28341196	830	844	adverse events	T046	C0877248
28341196	856	862	CTA-TA	T060	C0430022
28341196	866	873	ION-IVA	T060	C0430022
28341196	894	899	exams	T169	C4284036
28341196	905	914	ION-exams	T059	C0022885
28341196	916	924	ION-exam	T059	C0022885
28341196	925	928	CMI	T060	C2733072
28341196	929	934	rates	T081	C1521828
28341196	966	970	Mean	T081	C0444504
28341196	971	982	attenuation	T052	C0599946
28341196	1009	1013	mean	T081	C0444504
28341196	1014	1017	CNR	T081	C0456603
28341196	1044	1052	positive	T033	C1446409
28341196	1080	1091	attenuation	T052	C0599946
28341196	1096	1105	injection	T061	C1533685
28341196	1106	1110	rate	T081	C1521828
28341196	1122	1159	No immediate or delayed complications	T033	C4032686
28341196	1175	1184	ION-exams	T059	C0022885
28341196	1189	1208	intraosseous needle	T074	C1322770
28341196	1239	1245	CTA-TA	T060	C0430022
28341196	1247	1254	ION-IVA	T060	C0430022
28341196	1300	1303	CMI	T060	C2733072